Ausgabe 5/2016
Inhalt (7 Artikel)
Acute Myeloid Leukemias (H Erba, Section Editor)
What Is the Optimal Induction Therapy for Younger Fit Patients With AML?
Hugo F. Fernandez
Open Access
Myeloproliferative Disorders (C Harrison, Section Editor)
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
Neha Bhatnagar, Laure Nizery, Oliver Tunstall, Paresh Vyas, Irene Roberts
Myeloproliferative Disorders (C Harrison, Section Editor)
Investigation and Management of Erythrocytosis
Mary Frances McMullin
Open Access
Myeloproliferative Disorders (C Harrison, Section Editor)
The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
Gunnar Birgegård
Myeloproliferative Disorders (C Harrison, Section Editor)
How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera
Andreas Reiter, Claire Harrison
CART and Immunotherapy (M Ruella, Section Editor)
Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You
Marco Ruella, Carl H. June
Acute Lymphocytic Leukemias (K Ballen, Section Editor)
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances
Lynda M. Vrooman, Lewis B. Silverman